The current pharmacotherapy for diabetes involves insulin secretagogues, insulin sensitizers, alpha-glucosidase inhibitors, biguanides, incretin mimetics, sodium-glucose co-transport-2 inhibitors, amylin antagonists, and insulin. This evidence concerns the gene GCG and diabetes mellitus.